Literature DB >> 15550346

Alterations of neuroplasticity in depression: the hippocampus and beyond.

Eberhard Fuchs1, Boldizsár Czéh, Maarten H P Kole, Thomas Michaelis, Paul J Lucassen.   

Abstract

Early hypotheses on the pathophysiology of major depression were based on aberrant intrasynaptic concentrations of mainly the neurotransmitters serotonin and norepinephrine. However, recent neuroimaging studies have demonstrated selective structural changes across various limbic and nonlimbic circuits in the brains of depressed patients. In addition, postmortem morphometric studies revealed decreased glial and neuron densities in selected brain structures supporting the idea that major depression may be related to impairments of structural plasticity. Stressful life events are among the major predisposing risk factors for developing depression. Using the chronic psychosocial stress paradigm in male tree shrews, an animal model with a high validity for the pathophysiology of depressive disorders, we found that 1 month of stress reduced the in vivo concentrations of the brain metabolites N-acetyl-aspartate, choline-containing compounds, and (phospho)-creatine, as well as the proliferation rate in the dentate gyrus and the hippocampal volume. Even though long-lasting social conflict does not lead to a loss of principal cells, the hippocampal changes were accompanied by modifications in the incidence of apoptosis. Notably, these suppressive effects of social conflict on hippocampal structure could be counteracted by treatment with the antidepressant tianeptine. These findings support current theories proposing that major depressive disorders may be associated with impairment of structural plasticity and neural cellular resilience, and that antidepressants may act by correcting this dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550346     DOI: 10.1016/j.euroneuro.2004.09.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  66 in total

1.  Cognitive prescriptions.

Authors:  David E Vance; Greg Eagerton; Brenna Harnish; Peggy McKie; Pariya L Fazeli
Journal:  J Gerontol Nurs       Date:  2010-12-22       Impact factor: 1.254

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 3.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

4.  Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus.

Authors:  Peter J Gianaros; J Richard Jennings; Lei K Sheu; Phil J Greer; Lewis H Kuller; Karen A Matthews
Journal:  Neuroimage       Date:  2007-02-01       Impact factor: 6.556

Review 5.  What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus?

Authors:  Cheryl D Conrad
Journal:  Behav Cogn Neurosci Rev       Date:  2006-03

Review 6.  Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease.

Authors:  Bruce S McEwen; Peter J Gianaros
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Exercise neuroprotection in a rat model of binge alcohol consumption.

Authors:  J Leigh Leasure; Kimberly Nixon
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

8.  A pubertal immune challenge alters the antidepressant-like effects of chronic estradiol treatment in inbred and outbred adult female mice.

Authors:  N Ismail; A M Kumlin; J D Blaustein
Journal:  Neuroscience       Date:  2012-10-01       Impact factor: 3.590

9.  Peony glycosides protect against corticosterone-induced neurotoxicity in PC12 cells.

Authors:  Qing-Qiu Mao; Siu-Po Ip; Kam-Ming Ko; Sam-Hip Tsai; Ming Zhao; Chun-Tao Che
Journal:  Cell Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.046

10.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.